FDA wants heartburn drug pulled from market
Zantac is the most common brand of ranitidine. Photo: Yichuan Cao/NurPhoto via Getty Images
The Food and Drug Administration is asking all makers of ranitidine, a heartburn drug most commonly known by the brand name Zantac, to pull all forms of the medicine from the market.
The bottom line: Don't take any versions of this drug, which has been linked to cancer-causing contaminants.